近距离放射治疗全球市场规模、份额、成长分析（按管理类型、按产品）- 2023-2030 年产业预测

Global Brachytherapy Market Size, Share, Growth Analysis, By Dosage Type(HDR and LDR), By Product(Prostate Cancer, Gynecological Cancer) - Industry Forecast 2023-2030

出版日期: 2024年02月02日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球近距离放射治疗市场规模预计为5亿美元，将从2023年的5.4亿美元成长到2031年的9.9亿美元，预测期间（2024-2031年）复合年增长率为7.95%。成长。

全球近距离放射治疗市场的预期成长受到多种因素的推动，例如癌症发病率上升、技术进步以及近距离放射治疗采用率的显着增加。近距离放射治疗是放射治疗的一种，使用透过导管插入体内的放射性物质来治疗癌症。此方法使用人工产生的放射性核种，如铯137、铱192、金198、碘125和钯103，已被证明对治疗局部肿瘤非常有效。根据国际癌症研究机构（IARC）估计，全球癌症病例数约为1,930万例，预计到2030年将增加至2,460万例。癌症发生率上升是市场的主要驱动力。放射线治疗可单独使用或与手术、免疫疗法和化疗合併使用，用于多种目的，包括预防性、安宁疗护和根治性治疗。其用途广泛，加速了医疗专业人员的采用。放射治疗技术的最新进展使得能够精确地将高剂量输送到目标区域，同时最大限度地减少对邻近健康组织的伤害。这项进步显着提高了局部肿瘤的控制和治癒率，从而推动了对放射线治疗的需求。

自上而下和自下而上的方法已用于估计和检验全球近距离放射治疗市场的规模，并估计其他各个相关子市场的规模。用于估计市场规模的调查方法包括以下细节：透过二次研究确定市场的主要企业，并透过初步和二次研究确定每个地区的市场占有率。整个过程包括研究主要企业的年度和财务报告以及广泛的采访，以获得执行长、副总裁、董事和行销负责人等行业领导者的重要见解。所有股份比率和细分均使用二手资讯确定并使用主要资讯检验。本研究涵盖的所有可能影响市场的参数都经过广泛而详细的考虑，透过初步研究检验并进行分析，以获得最终的定量和定性资料。

全球近距离放射治疗市场細項分析

全球近距离放射治疗市场根据产品、给药类型、应用和区域进行细分。依产品划分，市场分为种子、施用器和后荷机、电子近距离治疗。依剂量类型，市场分为 HDR 和 LDR。依用途分为摄护腺癌、妇科癌、乳癌等。依地区划分，分为北美、欧洲、亚太地区、中东/非洲、拉丁美洲。

全球近距离放射治疗市场的驱动因素

微创治疗方法因其术后併发症少、住院时间短、恢復快而受到患者青睐。由于近距离放射治疗是一种微创治疗方法，因此通常可以在门诊进行治疗。对微创治疗的日益偏好是推动近距离放射治疗市场扩张的关键因素。

近距离放射治疗市场受到全球人口老化和预期寿命延长趋势的推动。老年人的癌症发生率普遍较高，近距离放射治疗已成为有效的治疗选择，特别是局部肿瘤。人口老化以及癌症筛检和诊断技术的进步正在增加对近距离放射治疗的需求。

全球近距离放射治疗市场的限制因素

近距离放射治疗需要专门的设备和基础设施来进行治疗计划、放射治疗和病人安全。初期成本（包括设备购置和安装）可能会很高。如此大的初始投资可能是一个挑战，特别是对于资源有限地区的卫生机构来说，这限制了近距离放射治疗的普及。

全球近距离放射治疗市场趋势

人们对保留器官的治疗的日益偏好正在推动近距离放射治疗的广泛普及，特别是在前列腺癌、乳腺癌和子宫颈癌等癌症中。近距离放射治疗可提供精确的放射治疗，最大限度地减少对附近健康组织的伤害，从而保护器官功能并提高患者的生活品质。向器官保存和微创治疗的转变扩大了近距离放射治疗的使用。

执行摘要
调查方法
母市场分析
主要市场考察
- 技术分析
- 价格分析
- 供应链分析
- 价值链分析
- 市场生态系统
- 智慧财产权分析
- 贸易分析
- Start-Ups分析
- 原料分析
- 创新矩阵
- 研发线产品分析
- 总体经济指标
- 主要投资分析
- 关键成功因素
- 竞争程度
市场动态及前景
- 市场动态
  - 促进因素
  - 机会
  - 抑制因素
  - 任务
- 监管形势
- 波特的分析
- 对未来中断的特殊考虑
全球近距离放射治疗市场：依管理类型
- 市场概况
- HDR 和 LDR
全球近距离放射治疗市场：按产品
- 市场概况
- 摄护腺癌
- 妇科癌症
- 乳癌
- 其他的
全球近距离放射治疗市场规模：按地区划分
- 市场概况
- 北美洲
  - 美国
  - 加拿大
- 欧洲
  - 德国
  - 西班牙
  - 法国
  - 英国
  - 其他欧洲地区
- 亚太地区
  - 中国
  - 印度
  - 日本
  - 韩国
  - 其他亚太地区
- 拉丁美洲
  - 巴西
  - 其他拉丁美洲地区
- 中东/非洲
  - 海湾合作委员会国家
  - 南非
  - 其他中东/非洲地区
竞争形势
- 前5名企业对比
- 主要企业市场定位（2021年）
- 主要市场参与者所采取的策略
- 关键成功策略
- 近期市集活动
- 主要企业市场占有率（2021年）
主要企业简介
- 埃克特和齐格勒 BEBIG（德国）
- 瓦里安医疗系统公司（美国）
- 医科达公司（瑞典）
- IsoAid LLC（美国）
- Theragenics 公司（美国）
- CR Bard, Inc.（美国）
- 波士顿科学公司（美国）
- 艾索瑞公司（美国）
- Nucletron BV（荷兰）
- 汇恆医疗股份有限公司（中国）
- iCAD, Inc.（美国）
- 医科达公司（瑞典）
- Nanobiotix SA（法国）
- BTG国际有限公司（英国）
- GE医疗集团（美国）
- IBA 全球（比利时）
- Cianna Medical, Inc.（美国）
- Theragenics 公司（美国）
- C4 Imaging LLC（美国）
- CIVCO 医疗解决方案（美国）
- RaySearch Laboratories AB（瑞典）
- Hologic, Inc.（美国）

简介目录

Product Code: SQMIG35D2138

Global Brachytherapy Market size was valued at USD 0.50 Billion in 2022 and is poised to grow from USD 0.54 Billion in 2023 to USD 0.99 Billion by 2031, at a CAGR of 7.95% during the forecast period (2024-2031).

The anticipated growth of the global brachytherapy market is fuelled by several factors, including the escalating prevalence of cancer, technological advancements, and a notable uptick in brachytherapy adoption. Brachytherapy, a type of radiation therapy, involves the insertion of radioactive materials into the body through catheters to treat cancer. This method proves highly efficacious for treating localized tumours, employing artificially generated radionuclides like Caesium-137, Iridium-192, Gold-198, Iodine-125, and Palladium-103. According to estimates from the International Agency for Research on Cancer (IARC), global cancer incidence stands at approximately 19.3 million cases, projected to increase to 24.6 million by 2030. The expanding burden of cancer serves as a primary market driver. Radiation therapy serves various purposes, including prophylactic, palliative, or curative treatment, either alone or in conjunction with surgery, immunotherapy, or chemotherapy. The diverse array of applications has spurred heightened adoption by medical professionals. Recent strides in radiation therapy techniques allow for precise delivery of high doses to target areas while minimizing harm to adjacent healthy tissues. This advancement significantly enhances localized tumour control and cure rates, consequently driving demand for radiation therapy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Brachytherapy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Brachytherapy Market Segmental Analysis

Global Brachytherapy Market is segmented on the basis of product, dosage type, application and region. By product, the market is segmented into seeds, applicators & after loaders, electronic brachytherapy. By dosage type, market is segmented into HDR and LDR. By application, the market is segmented into prostate cancer, gynaecological cancer, breast cancer, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Brachytherapy Market

Patients favour minimally invasive treatment methods because they lead to fewer post-operative complications, shorter hospital stays, and quicker recovery periods. Brachytherapy, being a minimally invasive treatment option, is often feasible on an outpatient basis. The rising preference for minimally invasive procedures is a key factor driving the expansion of the brachytherapy market.

The brachytherapy market is propelled by the global trend of an aging population and longer life expectancy. With cancer incidence typically higher among older individuals, brachytherapy emerges as a viable treatment choice, particularly for localized tumours. The combination of an aging population and improvements in cancer screening and diagnosis fuels the demand for brachytherapy procedures.

Restraints in the Global Brachytherapy Market

Brachytherapy necessitates specialized equipment and infrastructure for treatment planning, radiation delivery, and ensuring patient safety. The initial expenses, encompassing the acquisition and installation of equipment, can be substantial. This considerable upfront investment may pose a challenge for healthcare facilities, particularly in regions with limited resources, thereby constraining the uptake of brachytherapy.

Market Trends of the Global Brachytherapy Market

The increasing inclination towards treatments that preserve organs is driving the popularity of brachytherapy, particularly in cancers like prostate, breast, and cervical cancer. Brachytherapy offers precise radiation delivery, minimizing harm to nearby healthy tissues, thus maintaining organ function and enhancing patients' quality of life. This shift towards organ preservation and minimally invasive therapies has resulted in greater utilization of brachytherapy.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
  - Drivers
  - Opportunities
  - Restraints
  - Challenges
- Regulatory Landscape
- Porters Analysis
  - Competitive rivalry
  - Threat of Substitute Products
  - Bargaining Power of Buyers
  - Threat of New Entrants
  - Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
  - Political Impact
  - Economic Impact
  - Social Impact
  - Technical Impact
  - Environmental Impact
  - Legal Impact
Global Brachytherapy Market by Dosage Type
- Market Overview
- HDR and LDR
Global Brachytherapy Market by Product
- Market Overview
- Prostate Cancer
- Gynecological Cancer
- Breast Cancer
- Others
Global Brachytherapy Market Size by Region
- Market Overview
- North America
  - USA
  - Canada
- Europe
  - Germany
  - Spain
  - France
  - UK
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - South Korea
  - Rest of Asia-Pacific
- Latin America
  - Brazil
  - Rest of Latin America
- Middle East & Africa (MEA)
  - GCC Countries
  - South Africa
  - Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
  - By Development
  - By Company
  - By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Eckert & Ziegler BEBIG (Germany)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Varian Medical Systems, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Elekta AB (Sweden)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- IsoAid LLC (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Theragenics Corporation (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- C. R. Bard, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Boston Scientific Corporation (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Isoray Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Nucletron B.V. (Netherlands)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Huiheng Medical, Inc. (China)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- iCAD, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Elekta AB (Sweden)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Nanobiotix SA (France)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- BTG International Ltd. (United Kingdom)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- GE Healthcare (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- IBA Worldwide (Belgium)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Cianna Medical, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Theragenics Corporation (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- C4 Imaging LLC (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- CIVCO Medical Solutions (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- RaySearch Laboratories AB (Sweden)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments
- Hologic, Inc. (United States)
  - Company Overview
  - Business Segment Overview
  - Financial Updates
  - Key Developments